Burjeel Holdings reported a 44.5% year-on-year increase in net profit to AED 57 million for the first quarter ended March 31, 2026, while total revenue grew 5.1% to AED 1.34 billion.
EBITDA rose 11.2% to AED 201 million with margins expanding to 15.0% due to procurement optimization and disciplined cost management; normalized revenue growth reached 9.7% excluding the impact of the Unified Procurement Program (UPP).
Total patient volumes increased 7.2% to 1.8 million visits, underscoring robust demand for specialized care and supporting an 13.1% rise in operating cash flow to AED 161 million.
The Group improved its net leverage to 1.7x and confirmed that shareholders approved a full-year 2025 dividend of AED 120 million (approximately AED 0.02 per share) in April 2026.